CAR-T cell therapy
Autologous cell therapy for relapsed or refractory lymphoma and multiple myeloma at leading haematology centres.
Updated: 12 novembre 2026
Reference cost in China
48 000 USD
Typical stay
3–4 weeks
Waiting time
2–3 weeks
Direct access to public-hospital specialists
Start your confidential assessment
Describe the patient’s condition and upload recent imaging and records. Your medical advisor replies within 1 business day with a first assessment and specialist availability.
Submit records for review Encrypted transfer · No hidden fees for the assessment